Pub. L. No. 109-417, 120 Stat. 2831, codified in relevant part at 42 USC 247d–6a note
Section 405 of the Act provides for the Commission and the Department of Justice to participate in developing, implementing, monitoring and reporting on consultations among, and voluntary agreements established by, entities creating pandemic and biodefense drugs and vaccines under a limited antitrust exemption established by the Act.